When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
AIMT - First U.S. patients treated with Palforzia for peanut allergy
Aimmune Therapeutics Inc.
Aimmune Therapeutics (NASDAQ:AIMT) announces that the first patients in the U.S. are being treated with PALFORZIA [Peanut (Arachis hypogaea) Allergen Powder-dnfp], the first approved treatment for peanut allergy.
More news on: Aimmune Therapeutics, Inc., Healthcare stocks news, Stocks on the move,